On 4 March, the University of Washington (UW) signed a memorandum of understanding with the Aga Khan University (AKU) to initiate their existing partnership, with the aim of leveraging complementary strengths to expand research, service and education activities in low and middle-income countries. Under the agreement, the UW will offer AKU and AKDN technical advice and assistance pertaining to data and implementation sciences, access to formal degree and training programs, and will also support them in transforming AKU into a research-centered varsity. Both parties will also expand research endeavors and will offer joint student and faculty exchanges.
Related Posts
TSRI Researchers Find the Key to Drug Resistance in Breast Cancer
The scientists from The Scripps Research Institute (TSRI), University of Illinois, and the University of California (UC) have discovered two molecules of immune system that is believed to play a critical role in developing drug resistance in many tumors leading to breast cancer, especially in case of breast cancer that is estrogen driven. The immune […]
Blood tests for Alzheimer’s disease are currently available
Alzheimer’s disease, affecting 55 million globally with no cure, sees recent progress in drugs to slow its progression. Early intervention with these drugs is crucial, but current diagnostic methods often miss early signs. Evidence suggests Alzheimer’s indicators can be detected in the blood up to two decades prior to symptoms. Several US companies offer Alzheimer’s […]
Puma Biotechnology to present its abstract at ESMO 2017
Puma Biotechnology, Inc., a biopharmaceutical company announces the release of two abstracts on its drug neratinib. It will be presented at the European Society for Medical Oncology (ESMO) 2017 Congress, which is to be held from September 8 – 12 in Madrid, Spain. Reference Link: http://markets.businessinsider.com/news/stocks/puma-biotechnology-announces-publication-of-abstracts-for-esmo-2017-1002296389 Share via: Facebook X (Twitter) LinkedIn More